Seroprevalence of Antibodies to Group B Streptococcal Polysaccharides in Gambian Mothers and Their Newborns

Journal of the National Medical Association

Volumn 90, Issue 2, 1998, Pages 109-114

  Suara, Rahaman O ^a   Adegbola, R A ^b   Mulholland, E K ^b   Greenwood, B M ^b   Baker, C J ^b  

^a HOWARD UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

Gambia, Africa; Group B streptococci; Pregnancy

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; CAPSULAR POLYSACCHARIDE, STREPTOCOCCAL GROUP B TYPE II; STREPTOCOCCAL POLYSACCHARIDE TYPE III GROUP B;

ADULT; ARTICLE; BLOOD; EPIDEMIOLOGY; FEMALE; GAMBIA; HUMAN; IMMUNOLOGY; MICROBIOLOGY; NEWBORN; PASSIVE IMMUNIZATION; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; FEMALE; GAMBIA; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT, NEWBORN; POLYSACCHARIDES, BACTERIAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0031991578     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant 4th ed. Philadelphia, Pa: WB Saunders Co; 1995:980-1054.
2. Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics. 1981;68:544-549.
3. Baker CJ, Webb BJ, Kasper DL, Yow MD, Beachler CW. The natural history of group B streptococcal colonization in the pregnant woman and her offspring, II: determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus. Am J Obstet Gynecol. 1980;137:39-42.
4. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med. 1976;294:753-756.
5. Vogel LC, Boyer KM, Gadzala CA, Gadzala CA, Gotoff SP. Prevalence of type-specific group B streptococcal antibody in pregnant women. J Pediatr. 1980;96:1047-1051.
6. Beachler CW, Baker CJ, Kasper DL, Flemming DK, Webb BJ, Yow MD. Group B colonization and antibody status in lower socioeconomic parturient women. Am J Obstet Gynecol. 1979;133:171-174.
7. Gray BM, Pritchad DG, Dillon HC Jr. Seroepidemiology of group B Streptococcus type III colonization at delivery. J Infect Dis. 1989;159:1139-1142.
8. Suara RO, Adegbola RA, Baker CJ, Secka O, Mulholland EK, Greenwood BM. Carriage of group B Streptococcus in pregnant Gambian mothers and their infants. J Infect Dis. 1994;170:1316-1320.
9. Dawodu AH, Damole IO, Onile BA. Epidemiology of group B streptococcal carriage among pregnant women and their neonates: an African experience. Trop Geogr Med. 1983;35-145-150.
10. Rench MA, Baker CJ. Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr. 1993;122:638-640.
11. Galloway A, Deighton CM, Deady J, Marticorena IF, Efstatiou A. Type V group B streptococcal septicemia with bilateral endophthalmitis and septic arthritis. Lancet 1993;341:960-961. Letter.
12. Hervás JA, Gonzáles L, Gil J, Paoletti LC, Madoff LC, Benedí VJ. Neonatal group B streptococcal infection in Mallorca, Spain. Clin Infect Dis. 1993;16:714-718.
13. De Cueninck BJ, Eisentein TK, MacIntosh TS, Shockman GD, Swenson RM. Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type-specific polysaccharide of group B Streptococcus. Infect Immun. 1983;39:1155-1160.
14. Fleming DO. Mouse protection assay for group B Streptococcus type III. Infect Immun. 1982;35:240-247.
15. Feldman RG, Ferrante A. Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses J Infect Dis. 1990;162:883-887.
16. Baker CJ, Kasper DL, Davis CE. Immunochemical characterization of the 'native' type III polysaccharide of group B Streptococcus. J Exp Med. 1976;143:258-270.
17. Jennings HJ, Katzenellenbogen E, Lugowski C, Kasper DL. Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus. Biochemistry. 1983;22:1258-1264.
18. Jennings HJ, Lugowski C, Kasper DL. Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide. Biochemistry. 1981;20:4511-4518.
19. Wessels MR, DiFabio JL, Benedi V-J, Kasper DL, Michon F, Brisson J-R, et al. Structural determination and immunological characterization of the type V group B Streptococcus capsular polysaccharide. J Biol Chem. 1991;266:6714-6719.
20. Baker CJ, Edwards MS, Kasper DL. Immunogenicity of polysaccharides from type III group B Streptococcus. J Clin Invest. 1978;61:1107-1110.
21. Anthony BF, Concepcion IE, Concepcion NF, Vadheim CM, Jawahar T. Relation between maternal age and serum concentration of IgG antibody to type III GBS streptococci. J Infect Dis. 1994;170:717-720.
22. Linden V, Christensen KK, Christensen P. Type-specific serum antibodies against group B streptococci among pregnant women: relation to urogenital carriage and age. Scand J Infect Dis 1982;14:189-193.
23. Hall MA, Hickman ME, Baker CJ, Edwards MS. Complement and antibody in neutrophil-mediated killing of type V group B Streptococcus. J Infect Dis. 1994;170:88-93.